Evidence map›Paper›PMID 41714147›Full record

ArticleGenome research2026

Gene duplication is associated with gene diversification and potential neofunctionalization in lung cancer evolution.

Paul Ashford, Alexander M Frankell, Zofia Piszka, Camilla S M Pang, Mahnaz Abbasian, Maise Al Bakir, Mariam Jamal-Hanjani, Nicholas McGranahan, Charles Swanton, Christine A Orengo

Abstract read
In one paragraph

Article in Genome research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Paul AshfordInstitute of Structural and Molecular Biology, University College London, London WC1E 6BT, United Kingdom.ORCID 0000-0003-4079-0257
Alexander M FrankellCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London NW1 1AT, United Kingdom.ORCID 0000-0002-0341-7878
Zofia PiszkaInstitute of Structural and Molecular Biology, University College London, London WC1E 6BT, United Kingdom.
Camilla S M PangInstitute of Structural and Molecular Biology, University College London, London WC1E 6BT, United Kingdom.
Mahnaz AbbasianInstitute of Structural and Molecular Biology, University College London, London WC1E 6BT, United Kingdom.
Maise Al BakirCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, United Kingdom.
Mariam Jamal-HanjaniCancer Metastasis Laboratory, University College London Cancer Institute, London WC1E 6DD, United Kingdom.
Nicholas McGranahanCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, United Kingdom.ORCID 0000-0001-9537-4045
Charles SwantonCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London NW1 1AT, United Kingdom.
Christine A OrengoInstitute of Structural and Molecular Biology, University College London, London WC1E 6BT, United Kingdom; c.orengo@ucl.ac.uk.

Funding

Cancer Research UK BCRF-22-157Cancer Research UK C11496/A17786Cancer Research UK C11496/A30025Cancer Research UK C416/A21999Cancer Research UK EDDPMA-NOV21/100034Wellcome Trust 211179/Z/18/ZWellcome Trust 221327/Z/20/ZWellcome Trust SU2C-AACR-DT23-17
6 · The paper itself

Abstract

Tumors evolve through a process of selection on somatic mutations, driving cell division and tissue growth through aberrations in cell-cycle control. In non-small-cell lung cancer (NSCLC), genome instability occurs early in tumor growth, resulting in pronounced intratumor heterogeneity, including changes in gene copy number, and whole-genome doubling (WGD) in ∼75% of tumors. Gene duplication, genetic drift, and selection mediate functional diversification during evolution. In this study, we seek to identify the diversification and potential gene neofunctionalization of lung tumors in the TRACERx cohort. We develop a novel computational protocol to identify preduplication and postduplication mutations predicted to affect protein function. Mutations are analyzed using paralogs grouped into functional families with highly similar functions, identifying 355 functional impact events (FIEs) through their proximity and clustering near to functional sites. The use of functional family paralogs to map mutations to protein structures from the PDB helps predict putative rare driver events in lung tumors. By extending the analysis with high-quality structural models from AlphaFold using The Encyclopedia of Domains (TED), we find a significant increase in the diversity of both genes and functional families with postduplication FIEs in lung adenocarcinomas, including some metabolic enzymes with the potential to be neofunctional. The postduplication diversification of driver genes and functions may indicate selection for somatic copy number changes in lung tumors and an increased scope for tumor adaptations.

Indexed as

Carcinoma, Non-Small-Cell LungEvolution, MolecularGene DuplicationLung NeoplasmsGenetic VariationHumansMutation

Identifiers

PMID41714147
PMCPMC12951968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.